Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
Autor(a) principal: | |
---|---|
Data de Publicação: | 1995 |
Outros Autores: | , , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Revista da Sociedade Brasileira de Medicina Tropical |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015 |
Resumo: | The authors report a case of a male patient from Bacabal, MA with diffuse cutaneous leishmaniasis (DCL), for at least nine years, with 168 lesions on his body. These were tumour-like nodules with some ulceratmi. He usedpentavalent antimonial (glucantime®) and an association of gamma interferon plus glucantime with improvement of the lesions but relapsed later. Recently, pentamidine isethionate (pentacarinat®) was given a dosage of 4mg/kg/weight/day on alternate days for 20 applications. After 3 months a similar course of 10 application was given 2 times. Later he developed diabetic signs with weight loss of 10kg, polydypsia, polyuria and xerostomia. The lower limbs lesions showed signs of activity. Blood glucose levels normalised and remain like this at moment. Attention is drawn to the fact that pentamidine isethionate should be used as a therapy option with care, obeyng rigorous laboratory controls including a glucose tolerance test. |
id |
SBMT-1_526b448a30402b4429da9205710b0c64 |
---|---|
oai_identifier_str |
oai:scielo:S0037-86821995000400015 |
network_acronym_str |
SBMT-1 |
network_name_str |
Revista da Sociedade Brasileira de Medicina Tropical |
repository_id_str |
|
spelling |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasisDiffuse cutaneous leishmaniasisPentamidine isethionateDiabetes mellitusMaranhão StateThe authors report a case of a male patient from Bacabal, MA with diffuse cutaneous leishmaniasis (DCL), for at least nine years, with 168 lesions on his body. These were tumour-like nodules with some ulceratmi. He usedpentavalent antimonial (glucantime®) and an association of gamma interferon plus glucantime with improvement of the lesions but relapsed later. Recently, pentamidine isethionate (pentacarinat®) was given a dosage of 4mg/kg/weight/day on alternate days for 20 applications. After 3 months a similar course of 10 application was given 2 times. Later he developed diabetic signs with weight loss of 10kg, polydypsia, polyuria and xerostomia. The lower limbs lesions showed signs of activity. Blood glucose levels normalised and remain like this at moment. Attention is drawn to the fact that pentamidine isethionate should be used as a therapy option with care, obeyng rigorous laboratory controls including a glucose tolerance test.Sociedade Brasileira de Medicina Tropical - SBMT1995-12-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015Revista da Sociedade Brasileira de Medicina Tropical v.28 n.4 1995reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/S0037-86821995000400015info:eu-repo/semantics/openAccessCosta,Jackson Mauricio LopesMoraes,Marta Solange C.Saldanha,Ana Cristina R.Barral,AldinaBurattini,Marcelo N.eng2013-04-10T00:00:00Zoai:scielo:S0037-86821995000400015Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2013-04-10T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false |
dc.title.none.fl_str_mv |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
title |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
spellingShingle |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis Costa,Jackson Mauricio Lopes Diffuse cutaneous leishmaniasis Pentamidine isethionate Diabetes mellitus Maranhão State |
title_short |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
title_full |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
title_fullStr |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
title_full_unstemmed |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
title_sort |
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis |
author |
Costa,Jackson Mauricio Lopes |
author_facet |
Costa,Jackson Mauricio Lopes Moraes,Marta Solange C. Saldanha,Ana Cristina R. Barral,Aldina Burattini,Marcelo N. |
author_role |
author |
author2 |
Moraes,Marta Solange C. Saldanha,Ana Cristina R. Barral,Aldina Burattini,Marcelo N. |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Costa,Jackson Mauricio Lopes Moraes,Marta Solange C. Saldanha,Ana Cristina R. Barral,Aldina Burattini,Marcelo N. |
dc.subject.por.fl_str_mv |
Diffuse cutaneous leishmaniasis Pentamidine isethionate Diabetes mellitus Maranhão State |
topic |
Diffuse cutaneous leishmaniasis Pentamidine isethionate Diabetes mellitus Maranhão State |
description |
The authors report a case of a male patient from Bacabal, MA with diffuse cutaneous leishmaniasis (DCL), for at least nine years, with 168 lesions on his body. These were tumour-like nodules with some ulceratmi. He usedpentavalent antimonial (glucantime®) and an association of gamma interferon plus glucantime with improvement of the lesions but relapsed later. Recently, pentamidine isethionate (pentacarinat®) was given a dosage of 4mg/kg/weight/day on alternate days for 20 applications. After 3 months a similar course of 10 application was given 2 times. Later he developed diabetic signs with weight loss of 10kg, polydypsia, polyuria and xerostomia. The lower limbs lesions showed signs of activity. Blood glucose levels normalised and remain like this at moment. Attention is drawn to the fact that pentamidine isethionate should be used as a therapy option with care, obeyng rigorous laboratory controls including a glucose tolerance test. |
publishDate |
1995 |
dc.date.none.fl_str_mv |
1995-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0037-86821995000400015 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Medicina Tropical - SBMT |
publisher.none.fl_str_mv |
Sociedade Brasileira de Medicina Tropical - SBMT |
dc.source.none.fl_str_mv |
Revista da Sociedade Brasileira de Medicina Tropical v.28 n.4 1995 reponame:Revista da Sociedade Brasileira de Medicina Tropical instname:Sociedade Brasileira de Medicina Tropical (SBMT) instacron:SBMT |
instname_str |
Sociedade Brasileira de Medicina Tropical (SBMT) |
instacron_str |
SBMT |
institution |
SBMT |
reponame_str |
Revista da Sociedade Brasileira de Medicina Tropical |
collection |
Revista da Sociedade Brasileira de Medicina Tropical |
repository.name.fl_str_mv |
Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT) |
repository.mail.fl_str_mv |
||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br |
_version_ |
1752122149839044608 |